| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,704 |
4,078 |
$190K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,868 |
2,569 |
$155K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,269 |
1,888 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
639 |
579 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
294 |
264 |
$7K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,053 |
972 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,148 |
1,044 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
15 |
$931.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
80 |
77 |
$928.78 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$672.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,656 |
1,500 |
$630.81 |
| 81002 |
|
28 |
27 |
$69.00 |